Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Dr Agarwal's Eye Hospital Ltd

Your Vote -

Buy

75.00%

Hold

0.00%

Sell

25.00%

75.00%

4 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Dr Agarwal's Eye Hospital Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Dr. Agarwal's Ey - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter And

    28 Jan 2026, 5:57PM Dr Agarwals Eye Hospital Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 ,inter alia, to con
  • Dr. Agarwal's Ey has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2025

    20 Jan 2026, 7:30PM As of December 2025, 72.67% is owned by Indian Promoters and 27.33% by Public. <p align=justify> Top Promoter holding highest number of shares of Dr.
  • Dr. Agarwal's Ey - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    12 Jan 2026, 3:00PM As per the letter enclosed.

Key fundamentals

Evaluate the intrinsic value of Dr Agarwal's Eye Hospital Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 305.97 208.45 157.17 110.11 71.4424
Liabilities 305.97 208.45 157.17 110.11 71.4424
Equity 4.7 4.7 4.7 4.7 4.7
Gross Profit 118.5 91.06 74.69 57.6845 30.3734
Net Profit 54.65 46.36 36.92 24.1047 -1.4386
Cash From Operating Activities 94.48 89.77 69.62 56.6762 33.8734
NPM(%) 13.76 14.51 13.78 11.97 -1.02
Revenue 397.15 319.3 267.89 201.2145 139.809
Expenses 278.65 228.24 193.2 143.53 109.4356
ROE(%) 17.38 14.74 11.74 7.66 -0.45

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Dr Agarwal's Eye Hospital Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 709.00 2.46 0.00 2653.96 301.39 0.70
Lotus Eye Hospital and Institute Ltd 130.90 -2.39 408.09 9670.69 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 20.39 13.59 0.00 20079.56 -39.50 0.00
Astec Lifesciences Ltd 590.85 2.86 0.00 9119.69 -604.77 0.00

Company Info

The Company was incorporated on 22nd April 1994 with the Registrar of companies, Tamil Nadu at Madras and obtained the certificate of commencement of business of 12.07.94. Dr.Agarwal and his family are in the business of providing total eye care for the past three decades. Though the corporate entity Dr.Agarwal's Eye Hospital Limited is new, the promoters of this venture have a tack record of more than 35 years in successfully running the eye hospital. Upto 30th September, 1994, the eye care facility was provided by the Agarwal family through various partnership firms owned by the family members. From 01.10.94 onwards, the entire hospital business is carried on by the newly floated company. Dr.Agarwal's Eye Hospital Limited and all the firms which were in this business upto 30th September, 1994 have ceased to carry on their operations from 01.10.1994 onwards. As such Dr.Agarwal's Eye Hospital Limited has the distinct advantage of capitalising on the reputation built by the Agarwals over a period of 37 years and aim at further growth by carrying out immediate expansion. 2002 -Dr Agarwal's Eye Hospital Ltd has informed BSE that Dr Sunita Agarwal Wholetime Director and Mr Pankaj Sodhi Wholetime Director of the Company have resigned from the Board of Directors of the Company and they cease to be Directors of the company wef October 01, 2002. -Dr Agarwal's Eye Hospital Ltd has informed that Mr Mohd Ahmad has ceased to be a Director of the company on account of his death on November 12, 2002. 2004 -Dr Agarwal's Eye recommends final dividend of 12% 2005 -Dr Agarwal's Eye recommends final dividend of 12% 2006 --Dr Agarwal's Eye recommends final dividend of 12% 2007 --Dr Agarwal's Eye recommends final dividend of 15% 2008 -Dr Agarwals Eye has designated the E-mail ID investor@dragarwal.com for the purpose of registering grievance by investors. 2009 -The Company's Super Specialty Eye Hospital for Retinal Care at Chennai was inaugurated. 2010 -Dr Agarwals Eye has recommended Equity Dividend of Rs. 0.80 per Share (8%) 2011 -Dr Agarwals Eye have recommended a final dividend of 12% 2012 -Dr Agarwals Eye marks entry into 55th year of dedicated eye care services, the Company's Glued IOL Clinic at Chennai Main Hospital was inaugurated 2013 -Board has recommended a final dividend of 12% which is Rs. 1.20 per equity share of Rs. 10/- each. 2014 -Registered office of the company has been shifted from No. 19 (Old No. 13), Cathedral Road, Chennai - 600 086.To 3rd Floor, Buhari Towers,No. 4, Moores Road, Off Greams Road, Chennai - 600 006. Phone No: 91-44-39916669. --Board has recommended a final dividend of 12% which is Rs. 1.20 per equity share of Rs. 10/- each. 2018 -Agarwal's Eye Hospital performs new surgical treatment for Keratoconus. 2020 -Tamil Nadu CM inaugurates Dr. Agarwals Eye Hospital in Salem. 2021 -Ophthalmologists flag sharp rise in myopia among children. 2024-Dr Agarwals Eye Hospital Launches New Eye Hospital in Kakinada-Dr Agarwals Eye Hospital has introduced VISX Star S4, an advanced laser technology available in the market today for the treatment of near sightedness, farsightedness, and astigmatism-Dr Agarwals Eye Hospital Launches Relex SMILE PRO - Most Advanced Procedure for Myopia, in Chennai2025-Dr Agarwals Eye Hospital and Menicon Co. Ltd Collaborate to Advance Myopia Control with Cutting-Edge Contact. Lenses

The Company was incorporated on 22nd April 1994 with the Registrar of companies, Tamil Nadu at Madras and obtained the certificate of commencement of business of 12.07.94. Dr.Agarwal and his family are in the business of providing total eye care for the past three decades. Though the corporate entity Dr.Agarwal's Eye Hospital Limited is new, the promoters of this venture have a tack record of more than 35 years in successfully running the eye hospital. Upto 30th September, 1994, the eye care facility was provided by the Agarwal family through various partnership firms owned by the family members. From 01.10.94 onwards, the entire hospital business is carried on by the newly floated company. Dr.Agarwal's Eye Hospital Limited and all the firms which were in this business upto 30th September, 1994 have ceased to carry on their operations from 01.10.1994 onwards. As such Dr.Agarwal's Eye Hospital Limited has the distinct advantage of capitalising on the reputation built by the Agarwals over a period of 37 years and aim at further growth by carrying out immediate expansion. 2002 -Dr Agarwal's Eye Hospital Ltd has informed BSE that Dr Sunita Agarwal Wholetime Director and Mr Pankaj Sodhi Wholetime Director of the Company have resigned from the Board of Directors of the Company and they cease to be Directors of the company wef October 01, 2002. -Dr Agarwal's Eye Hospital Ltd has informed that Mr Mohd Ahmad has ceased to be a Director of the company on account of his death on November 12, 2002. 2004 -Dr Agarwal's Eye recommends final dividend of 12% 2005 -Dr Agarwal's Eye recommends final dividend of 12% 2006 --Dr Agarwal's Eye recommends final dividend of 12% 2007 --Dr Agarwal's Eye recommends final dividend of 15% 2008 -Dr Agarwals Eye has designated the E-mail ID investor@dragarwal.com for the purpose of registering grievance by investors. 2009 -The Company's Super Specialty Eye Hospital for Retinal Care at Chennai was inaugurated. 2010 -Dr Agarwals Eye has recommended Equity Dividend of Rs. 0.80 per Share (8%) 2011 -Dr Agarwals Eye have recommended a final dividend of 12% 2012 -Dr Agarwals Eye marks entry into 55th year of dedicated eye care services, the Company's Glued IOL Clinic at Chennai Main Hospital was inaugurated 2013 -Board has recommended a final dividend of 12% which is Rs. 1.20 per equity share of Rs. 10/- each. 2014 -Registered office of the company has been shifted from No. 19 (Old No. 13), Cathedral Road, Chennai - 600 086.To 3rd Floor, Buhari Towers,No. 4, Moores Road, Off Greams Road, Chennai - 600 006. Phone No: 91-44-39916669. --Board has recommended a final dividend of 12% which is Rs. 1.20 per equity share of Rs. 10/- each. 2018 -Agarwal's Eye Hospital performs new surgical treatment for Keratoconus. 2020 -Tamil Nadu CM inaugurates Dr. Agarwals Eye Hospital in Salem. 2021 -Ophthalmologists flag sharp rise in myopia among children. 2024-Dr Agarwals Eye Hospital Launches New Eye Hospital in Kakinada-Dr Agarwals Eye Hospital has introduced VISX Star S4, an advanced laser technology available in the market today for the treatment of near sightedness, farsightedness, and astigmatism-Dr Agarwals Eye Hospital Launches Relex SMILE PRO - Most Advanced Procedure for Myopia, in Chennai2025-Dr Agarwals Eye Hospital and Menicon Co. Ltd Collaborate to Advance Myopia Control with Cutting-Edge Contact. Lenses

Read More

Parent Organisation

Dr. Agarwal's Eye Hospital Ltd.

Founded

22/04/1994

Managing Director

Dr.Amar Agarwal

NSE Symbol

FAQ

The current price of Dr Agarwal's Eye Hospital Ltd is

The 52-week high for Dr Agarwal's Eye Hospital Ltd is

The market capitalization of Dr Agarwal's Eye Hospital Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Dr Agarwal's Eye Hospital Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Dr Agarwal's Eye Hospital Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Dr Agarwal's Eye Hospital Ltd shares.

The CEO of Dr Agarwal's Eye Hospital Ltd is Dr.Amar Agarwal, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT